cancer drugs

Oncology

Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.

News

China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.

News

The FDA has laid out a framework to use 'prior knowledge' on manufacturing, nonclinical, and clinical data to support cell and gene therapy filings.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.